Atherosclerotic changes have not been demonstrated directly in asymptomatic hyperglycaemic non-diabetic subjects, although high mortality due to coronary heart disease has been reported. We measured arterial wall thickness non-invasively, in order to directly demonstrate atherosclerosis of the carotid arteries of hyperglycaemic non-diabetic subjects and to evaluate its risk factors.
Several prospective studies [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] have suggested the occurrence of advanced atherosclerosis in coronary arteries and cerebral arteries in subjects with elevated blood glucose concentrations. In the Whitehall study [1, 2] , stroke mortality and coronary heart disease (CHD) mortality were increased approximately twofold for subjects with impaired glucose tolerance (IGT), defined as a blood-glucose level above 5.3 mmol/1. Also, the Bedford survey indicated that age-corrected CHD-mortality rates were higher for borderline diabetic patients than control subjects [3] . Mean + SEM. HDL-C, HDL cholesterol; LDL-C, LDL cholesterol; BG0, pre-stimulated blood glucose; IRI0, pre-stimulated plasma insulin; ZPG, area under plasma glucose concentration curve after 75-g OGTT; ZIRI, area under plasma insulin concentration curve after 75-g OGTT.
HL-Risk, number of subjects with either T-Chol > 5.69 mmol/1, TG > 1.70 mmol/1. HDL-C < 1.03 mmol/1 or taking hypolipidaemic drugs. HT-Risk. number of subjects with either systolic blood pressure > 160. diastolic blood pressure > 95 mm Hg, or taking anti-hypertensive drugs. SM-Risk, number of subjects who smoke more than one pack of cigarettes per day for 20 years
The Paris prospective study [4] [5] [6] [7] pointed out that the annual CHD mortality rates were increased almost twofold in subjects with IGT compared with those in normoglycaemic subjects. However, although symptomatic subjects have been examined by invasive coronary angiography [13, 14] , information on asymptomatic atherosclerosis in asymptomatic hyperglycaemia is scarce. Now this can be done using high resolution Bmode imaging of the carotid artery [15] [16] [17] [18] [19] [20] [21] [22] , which enables direct and non-invasive in vivo monitoring of carotid atherosclerosis even in subjects as young as 7 years old [22] . Because of its high-distance resolution, we were able to demonstrate, for the first time, a high prevalence of increased thickness of the carotid arteries in asymptomatic hyperglycaemic non-diabetic subjects. Predictors of carotid atherosclerosis in these subjects were analysed.
Subjects, materials and methods

Assessment of atherosclerosis.
Ultrasonographic scanning of the carotid arteries was performed using an echotomographic system (EUB-450, Hitachi Medico, Tokyo, Japan) with an electrical linear transducer (midfrequency of 7.5 MHz). The axial resolution of this system was at least 0.3 ram. Scanning of the extracranial carotid arteries in the neck was performed bilaterally in three different (i. e. anterior-oblique, lateral, and posterior-oblique) longitudinal projections as well as the transverse projection, as reported in our previous papers [20] [21] [22] . All the images were photographed. The scan lasted for an average of 30 rain.
The intimal plus medial thickness defined by Pignoli et al. [15, 16] was measured as the distance from the leading edge of the first echogenic line to the leading edge of the second echogenic line. At each longitudinal projection, the site of the greatest thickness was sought along the arterial walls which are nearest the skin and farthest from the skin through the common carotid artery to the internal carotid artery. Three determinations of intimal plus medial thickness were conducted at the site of the greatest thickness and at two points. ] cm upstream and 1 cm downstream from the site of the greatest thickness. These three determinations were averaged. The greatest value among the six averaged intimal plus medial thicknesses (three from the left and three from the right) was used as the representative value ([MT) for each individual. All scans were conducted by physicians (H. M. and H.N.) who were unaware of the clinical characteristics of the studied subjects. Determination of IMT on the photograph was performed by a physician (M. K.). The reproducibility of the IMT measurement was examined by conducting another scan 1 week later on eight participants. The mean difference in IMT between these two determinations was 0.01 ram. and the standard deviation was 0.04 mm0 demonstrating good reproducibility for repeated measurements, as described previously [15, 16, 21, 22] .
Patients. A total of 112 hyperglycaemic non-diabetic subjects aged 22-81 (95 males and 17 females), were recruited from among office workers, who were diagnosed as having glucose intolerance after oral glucose load (2-h plasma glucose > 6.7 mmol/1). The 75-g oral glucose load was administered a second time to selected subjects with impaired glucose tolerance (IGT; 2-h plasma glucose _>7.8 mmol/1) according to World Health Organisation criteria [23] non-IGT subjects (non-IGT; 7.8 mmol/1 > 2-h plasma glucose _> 6.7 mmol/1, or 1-h plasma glucose > 8.9 mmol/1 and 2-h plasma glucose < 6.7 mmol/1) according to the criteria of the Japanese Diabetes Association [24] . Careful examination of medical histories showed that these subjects were free of symptoms due to CHD, cerebrovascular diseases and peripheral vascular diseases. Blood was drawn for analyses of serum total cholesterol (T-Chol) and HDL-cholesterol (HDL-C), serum triglycerides (TG) and haemoglobin Ale levels before the oral glucose load; blood was also drawn at 30, 60,90 and 120 rain for analyses of plasma glucose and insulin concentrations. T-Chol, HDL-C, TG, plasma glucose, plasma insulin concentration and haemoglobin Alo level were determined by standard laboratory techniques. The characteristics of the subjects are described in Table 1 . Two hundred and sixteen male non4nsulin-dependent 9 (NIDDM) patients aged 30-86 years were recruited from among outpatients of Osaka University Hospital. The definition of NIDDM was based on World Health Organisation criteria. Each patient who fulfilled the following inclusion criteria was considered for the study: 1) no episodes of ketoacidosis and absence of ketonuria; 2)diagnosis of diabetes after 30 years of age; 3) insulin therapy (if any) started after at least 5 years of known disease; 4) body mass index less than 30 kg/ m2; 5) absence of overt diabetic nephropathy or other renal tract disease and 6) no evidence of cardiac failure.
Fifty-five hospital male employees or non-diabetic healthy males aged 25--76 years attending Osaka University Hospital without hyperlipidaemia, hypertension, cardiovascular disease, cerebrovascular disease, or peripheral vascular disease served as control subjects. Normal blood glucose levels in these subjects were assessed with the 75-g oral glucose tolerance test according to the criteria of the Japanese Diabetes Association.
Lifeqong exposure to smoking (pack-years) was estimated as the product of years of smoking and the mean number of cigarettes smoked daily at the time of examination. Blood pressure was measured with a mercury sphygmomanometer. After 5 rain rest in the supine position, three measurements were made in the sitting position and the means of these determinations were used in the present study. Low density lipoprotein cholesterol (LDL-C) was estimated by the Friedewald equation [25] . Non-HDL-cholesterol (non-HDL-C) was calculated as follows (non-HDL-C = T-Chol-HDL-C).
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The subjects were considered to be hypertensive (n = 17) if they were taking antihypertensive agents, and/or if systolic blood pressure was greater than 160 mmHg, and/or if diastolic blood pressure was greater than 95 mmHg. Dyslipidaemia was considered to be present for subjects (n = 60) taking h ypolipidaemic drugs and/or if the serum cholesterol level was greater than 5.69 mmol/1, if the TG level was greater than 1.70 mmol/1, or if HDL cholesterol was less than 1.03 mmol/1. Subjects were considered to have a smoking habit (n = 40) if patients had smoked for more than 20 pack-years, Body mass index (BMI) of the subjects studied was less than 30 kg/m 2.
A resting 12qead ECG was done for all the subjects. The double Master two-step test was done for the subjects (24 non-IGT and IGT, 65 diabetic patients) who showed abnormal resting ECG. In this study CHD was diagnosed if a subject showed the following ECG findings: 1) major Q-QS changes [26] , 2) a positive double Master two-step test [27] .
Statistical analysis
Data are presented as mean + SEM. Values of IMT and clinical parameters among the study groups were compared by oneway ANOVA. Chi-square analysis was used to evaluate the significance of the prevalence rate of ECG-indicated CHD.
Stepwise forward and backward multiple regression analysis was performed to account for the effects of different variables on IMT of non-IGT and IGT subjects who had not been given antihypertensive or hypolipidaemic drugs (n = 64). In this analysis, F values for inclusion and exclusion of variables were set as 2.0. These statistical analyses were carried out using the HALBAU (Gendai Sugaku-sha, Kyoto, Japan) statistical package [28] on a personal computer (PC-9801 NS/R, NEC, Tokyo, Japan). Statistical significance was determined as p less than 0.05.
Results
Non-IGT subjects aged 22-29 years had significantly greater IMT than male control subjects aged 25-29 years (0.717 + 0.054 vs 0.525 + 0.018 mm, p < 0.01) (Fig. 1) . . IMTs of male control subjects were less than 1.1 mm. Thus, the criteria of carotid atherosclerosis was set as the upper limit of IMT in the normal control subjects (1.1 mm) as previously described [21, 22] . There were no significant differences in IMTs among non-IGT subjects, IGT subjects and NIDDM patients from 30-39 years to 60 years and more. Non-IGT subjects had significantly lower fasting plasma glucose, ZPG, and HbAlc levels than IGT subjects. Non-IGT subjects showed higher (but not significantly) triglyceride levels (2.34 + 0.29 mmol/l) than IGT subjects (1.84 + 0.14 mmol/1). Stepwise multiple variate analysis (Table 2 ) demonstrated that the risk factors in IMT of both non-IGT and IGT subjects were age, systolic blood pressure, pack-years of smoking and fasting blood glucose (r 2 = 0.344), when the F value for inclusion was set as 2. However, the pack-years of smoking and fasting blood glucose did not reach statistical significance.
The hyperglycaemic non-diabetic patients without other risk factors (risk 1) (n = 13, age 49.4 + 3.7 years) had a significantly higher IMT than agematched male control subjects (n = 23, age 49.8 + 1. Fig.2) . The hyperglycaemic non-diabetic subjects whose IMTs were more than 1.1 mm showed a significantly higher prevalence rate of ECG-indicated CHD than those without carotid atherosclerosis (IMT < 1.1 ram) (11.1 vs 0.0%, Fig.3 ). The NIDDM patients whose IMTs were more than 1.1 mm showed a significantly higher prevalence of ECG abnormality than those without carotid atherosclerosis (IMT < 1.1 mm) (10.5 vs 1.0 %). Half (2 of 4) of the subjects with obesity (BMI > 25.0 %), high triglyceride level (> 1.70 mmol/ 1), low HDL cholesterol level (< 1.03 retool/l), and hypertensive risk showed a history of asymptomatic myocardial infarction.
Discussion
A series of studies [15, 16] has indicated that the IMT determined by B-mode imaging is comparable to the thickness of the IMT measured by pathological and histological examinations. Pignoli et al. [16] showed the highly linear relationship of the IMT measured by B-mode imaging with the thickness of intimal plus medial complexes determined by histological examination of subjects 20-25 years old, who were found to have IMT of 0.5 mm. The echotomographic system with an electrical linear transducer (midfrequency of 7.5 MHz) employed in the present study has an axial resolution of 0.3 ram. In this study, we used this method to determine early atherosclerosis in subjects with elevated blood glucose concentrations indicative of glucose intolerance but below those diagnostic of diabetes mellitus.
In this study, asymptomatic hyperglycaemic subjects were recruited from office workers who were given annual examinations of fasting plasma glucose, several lipid profiles, blood pressure levels, and urine samples. When the fasting plasma glucose level was over 6.1 mmol/1 or urine tested positive for glucose, they were given a 75-g oral glucose tolerance test. The subjects were mostly male and their carotid IMTs were compared with those of normal males and NIDDM males.
Non-IGT and IGT subjects showed significantly greater IMTs than male control subjects from 30-39 years to 60 years of age and over. Non-IGT subjects aged 22-29 years had IMTs 0.192 mm greater Stepwise multivariant regression analysis was done on 75 borderline diabetic patients to whom no medication had been given. Sex: men = 1, women = 0. Pack years of smoking was estimated as the product of years of smoking and the mean number of packs smoked daily.
than age-matched male control subjects. By considering the detection limit (0.3 mm) and discrimination limit of this method (0.1 mm), these data indicate the progression of atherosclerosis in carotid arteries of young hyperglycaemic non-diabetic patients. There were no significant differences in IMTs among non-IGT subjects, IGT subjects and NIDDM patients from 30-39years to 60years and over. These data were comparable to the Bedford survey [3] in which male borderline diabetic patients were found to have CHD mortality compatible with that of male diabetic patients.
In this study, for example, borderline diabetic patients of 40-49 years old showed increased thickness of their carotid arterial wall of 1.06 mm. This value is greater than IMT (0.67 mm) of hyperlipidaemic patients (46 + 6.0 years old) reported by Poli et al. [17] . These data showed a possibility that borderline diabetic patients have greater thickness of the carotid artery than hyperlipidaemic patients.
Stepwise multiple variate analysis demonstrated that the risk factors for IMT of non-IGT and IGT subjects as a group were age and systolic blood pressure. The pack-years of smoking and the fasting plasma glucose level were related to IMT (F values > 2.0) but were not significant independent predictors of IMT of hyperglycaemic subjects (Table 2) . Among these risk factors, the significance of systolic blood pressure and smoking was pointed out by the Whitehall study [1, 2] and the Bedford survey [3] . Higher plasma insulin level was found to be a risk factor in the Paris study [4] [5] [6] [7] and the Helsinki Policemen study [8] . In the Paris study, the plasma triglyceride level was the only factor positively and significantly associated with coronary death [6] . The Honolulu Heart Program indicated that post-challenge hyperglycaemia was an independent risk factor of CHD [11, 12] . Significant association of hyperlipidaemia and hypertension noted in subjects with IGT [29] sug, gested that the discrepancy of risk factors between the present study and the prospective studies might be due to differences in race or study design.
IMT was linearly related to the accumulation of atherogenic risks, such as hyperglycaemia, hypertension, hyperlipidaemia or smoking habit. We have already shown that although IMT increased with age, it never exceeded 1.1 mm in normal individuals [21] . This value is comparable to that mentioned previously [16] . Therefore, we adopted 1.1 mm as a cutoff value to determine the existence of carotid atherosclerosis. All subjects except two with these four risk factors showed advanced carotid atherosclerosis (IMT >_ 1.1 mm). These data indicate that such risks might cause additive rather than synergistic progression of atherosclerosis, as reported for diabetic and non-diabetic subjects [30] .
The hyperglycaemic subjects without other risk factors still showed significantly advanced carotid atherosclerosis. This implies that 'mild hyperglycaemia' can cause progression of atherosclerosis. Several possible mechanisms were proposed by which hyperglycaemia may cause atherosclerosis. Increased glycation of circulation lipoproteins observed in diabetes [31] reduces their binding to the LDL receptor [32] . Also, glycated HDL is cleared from plasma at an enhanced rate [33] and its ability to stimulate chol-esterol efflux from arterial cells is diminished. Increased glycation of collagen, well-described in diabetic patients [34] , stimulates platelet aggregation to a greater extent than does non-glycated collagen [35] . Recently, advanced glycation endproduct proteins have been shown to induce the transendothelial migration of monocytes and the subsequent expression of platelet-derived growth factor by macrophages [36] .
The hyperglycaemic non-diabetic patients we studied showed a high prevalence of hyperlipidaemia (76 of 112)and hypertension (24 of 112). A high prevalence of these abnormalities has also been reported by Laakso and Barrett-Connor [29] . These abnormalities have been suggested to result from insulin resistance or hyperinsulinaemia [37, 38] which may lead to a high CHD mortality rate, termed syndrome X [39] or the deadly quartet [40] . Another possibility, suggested by Laakso et al. [41] , is that insulin resistance rather than hyperinsulinaemia causes the progression of atherosclerosis.
IMTis a clinically useful quantitative index of carotid atherosclerosis as suggested by several investigators [15] [16] [17] [18] [19] [20] [21] [22] . The atherosclerotic processes occurring in the coronary arteries, extracranial carotid arteries, and peripheral arteries in the legs appear to be pathologically identical [42] . Also, a correlation between coronary and carotid atherosclerosis has been noted in previous autopsy studies [43, 44] . The present study clearly demonstrates that asymptomatic hyperglycaemic non-diabetic subjects had increased carotid arterial wall thickness, comparable to that of agematched diabetic patients. The high prevalence of ECG-indicated CHD in hyperglycaemic non-diabetic subjects and NIDDM males with increased thickness of carotid arterial wall indicates thata high CHD mortality rate can be anticipated in these subjects.
The present study showed that B-mode imaging of carotid arteries could reveal increased thickness of the carotid arterial wall in asymptomatic hyperglycaemic non-diabetic subjects even as young as aged 22-29 years. Impaired glucose tolerance, dyslipidaemia, hypertension, and smoking remain as additive risk factors for carotid atherosclerosis.
